Literature DB >> 20147607

Dietary fructose accelerates the development of diabetes in UCD-T2DM rats: amelioration by the antioxidant, alpha-lipoic acid.

Bethany P Cummings1, Kimber L Stanhope, James L Graham, Joseph L Evans, Denis G Baskin, Steven C Griffen, Peter J Havel.   

Abstract

Sustained fructose consumption has been shown to induce insulin resistance and glucose intolerance, in part, by promoting oxidative stress. Alpha-lipoic acid (LA) is an antioxidant with insulin-sensitizing activity. The effect of sustained fructose consumption (20% of energy) on the development of T2DM and the effects of daily LA supplementation in fructose-fed University of California, Davis-Type 2 diabetes mellitus (UCD-T2DM) rats, a model of polygenic obese T2DM, was investigated. At 2 mo of age, animals were divided into three groups: control, fructose, and fructose + LA (80 mg LA.kg body wt(-1).day(-1)). One subset was followed until diabetes onset, while another subset was euthanized at 4 mo of age for tissue collection. Monthly fasted blood samples were collected, and an intravenous glucose tolerance test (IVGTT) was performed. Fructose feeding accelerated diabetes onset by 2.6 +/- 0.5 mo compared with control (P < 0.01), without affecting body weight. LA supplementation delayed diabetes onset in fructose-fed animals by 1.0 +/- 0.7 mo (P < 0.05). Fructose consumption lowered the GSH/GSSG ratio, while LA attenuated the fructose-induced decrease of oxidative capacity. Insulin sensitivity, as assessed by IVGTT, decreased in both fructose-fed and fructose + LA-supplemented rats. However, glucose excursions in fructose-fed LA-supplemented animals were normalized to those of control via increased glucose-stimulated insulin secretion. Fasting plasma triglycerides were twofold higher in fructose-fed compared with control animals at 4 mo, and triglyceride exposure during IVGTT was increased in both the fructose and fructose + LA groups compared with control. In conclusion, dietary fructose accelerates the onset of T2DM in UCD-T2DM rats, and LA ameliorates the effects of fructose by improving glucose homeostasis, possibly by preserving beta-cell function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20147607      PMCID: PMC2867512          DOI: 10.1152/ajpregu.00468.2009

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  45 in total

Review 1.  Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential.

Authors:  Kate Petersen Shay; Régis F Moreau; Eric J Smith; Anthony R Smith; Tory M Hagen
Journal:  Biochim Biophys Acta       Date:  2009-08-04

Review 2.  Alpha-lipoic acid: a metabolic antioxidant and potential redox modulator of transcription.

Authors:  L Packer; S Roy; C K Sen
Journal:  Adv Pharmacol       Date:  1997

3.  Prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoic acid.

Authors:  Adil El Midaoui; Jacques de Champlain
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

Review 4.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.

Authors:  Joseph L Evans; Ira D Goldfine; Betty A Maddux; Gerold M Grodsky
Journal:  Endocr Rev       Date:  2002-10       Impact factor: 19.871

5.  Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients.

Authors:  S K Jain; R McVie
Journal:  Diabetes       Date:  1999-09       Impact factor: 9.461

6.  Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial.

Authors:  S Jacob; P Ruus; R Hermann; H J Tritschler; E Maerker; W Renn; H J Augustin; G J Dietze; K Rett
Journal:  Free Radic Biol Med       Date:  1999-08       Impact factor: 7.376

7.  Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle.

Authors:  Woo Je Lee; Kee-Ho Song; Eun Hee Koh; Jong Chul Won; Hyoun Sik Kim; Hye-Sun Park; Min-Seon Kim; Seung-Whan Kim; Ki-Up Lee; Joong-Yeol Park
Journal:  Biochem Biophys Res Commun       Date:  2005-07-08       Impact factor: 3.575

Review 8.  Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance.

Authors:  Kimber L Stanhope; Peter J Havel
Journal:  Curr Opin Lipidol       Date:  2008-02       Impact factor: 4.776

Review 9.  Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup.

Authors:  Kimber L Stanhope; Peter J Havel
Journal:  Am J Clin Nutr       Date:  2008-12       Impact factor: 7.045

Review 10.  Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

Authors:  Joseph L Evans; Ira D Goldfine; Betty A Maddux; Gerold M Grodsky
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

View more
  25 in total

1.  Effects of lipoic acid on AMPK and adiponectin in adipose tissue of low- and high-fat-fed rats.

Authors:  Pedro L Prieto-Hontoria; Patricia Pérez-Matute; Marta Fernández-Galilea; J Alfredo Martínez; María J Moreno-Aliaga
Journal:  Eur J Nutr       Date:  2012-06-05       Impact factor: 5.614

2.  The health implications of sucrose, high-fructose corn syrup, and fructose: what do we really know?

Authors:  James M Rippe
Journal:  J Diabetes Sci Technol       Date:  2010-07-01

Review 3.  Nutritional supplements and their effect on glucose control.

Authors:  Tanya Lee; Jean-Jacques Dugoua
Journal:  Curr Diab Rep       Date:  2011-04       Impact factor: 4.810

4.  Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake.

Authors:  Carlos A Roncal-Jimenez; Miguel A Lanaspa; Christopher J Rivard; Takahiko Nakagawa; L Gabriela Sanchez-Lozada; Diana Jalal; Ana Andres-Hernando; Katsuyuki Tanabe; Magdalena Madero; Nanxing Li; Christina Cicerchi; Kim Mc Fann; Yuri Y Sautin; Richard J Johnson
Journal:  Metabolism       Date:  2011-04-12       Impact factor: 8.694

5.  Catechin and quercetin attenuate adipose inflammation in fructose-fed rats and 3T3-L1 adipocytes.

Authors:  Marcela A Vazquez Prieto; Ahmed Bettaieb; Cecilia Rodriguez Lanzi; Verónica C Soto; Diahann J Perdicaro; Claudio R Galmarini; Fawaz G Haj; Roberto M Miatello; Patricia I Oteiza
Journal:  Mol Nutr Food Res       Date:  2015-03-11       Impact factor: 5.914

Review 6.  New insights on the risk for cardiovascular disease in African Americans: the role of added sugars.

Authors:  Karim R Saab; Jessica Kendrick; Joseph M Yracheta; Miguel A Lanaspa; Maisha Pollard; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 10.121

7.  Perinatal triphenyl phosphate exposure accelerates type 2 diabetes onset and increases adipose accumulation in UCD-type 2 diabetes mellitus rats.

Authors:  Adrian J Green; James L Graham; Eduardo A Gonzalez; Michael R La Frano; Syrago-Styliani E Petropoulou; June-Soo Park; John W Newman; Kimber L Stanhope; Peter J Havel; Michele A La Merrill
Journal:  Reprod Toxicol       Date:  2016-07-12       Impact factor: 3.143

8.  Reduced-calorie avocado paste attenuates metabolic factors associated with a hypercholesterolemic-high fructose diet in rats.

Authors:  María Elena Pahua-Ramos; Leticia Garduño-Siciliano; Lidia Dorantes-Alvarez; German Chamorro-Cevallos; Julieta Herrera-Martínez; Obed Osorio-Esquivel; Alicia Ortiz-Moreno
Journal:  Plant Foods Hum Nutr       Date:  2014-03       Impact factor: 3.921

9.  THE EFFECT OF SHORT TERM ALPHA LIPOIC ACID ADMINISTRATION ON ADIPONECTIN AND BODY WEIGHT IN TYPE 2 DIABETES MELLITUS PATIENTS.

Authors:  H Usta Atmaca; F Akbas
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Oct-Dec       Impact factor: 0.877

Review 10.  Obesity-associated oxidative stress: strategies finalized to improve redox state.

Authors:  Isabella Savini; Maria Valeria Catani; Daniela Evangelista; Valeria Gasperi; Luciana Avigliano
Journal:  Int J Mol Sci       Date:  2013-05-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.